Development of Inactivated Poliovirus Vaccine and Legacy of Jonas Salk

The chapter explores the creation of the inactivated poliovirus vaccine by Jonas Salk in the 1950s, including a reference to the Cutter Laboratories incident. It discusses the history of vaccine litigation, the shift from oral polio vaccine to IPV, and the legacy of the Salk Institute. Additionally, it delves into research at the institute in the 1970s on immune system-cancer connections and the use of immunotherapy using viruses for cancer treatment.